Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma Low-density Lipoprotein (LDL) level. The disease is caused by several different mutations in the LDL Receptor (LDLR) gene. Several mutations have been reported in this gene in patients from several ethnic groups. Early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infraction by the available therapeutic methods. The techniques available for determining the number of the functional LDLR molecules are difficult to carry out and expensive. Our study presents mutation analysis of the LDLR gene in 24 Indian families wi...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by a multitude of low-den...
Familial Hypercholesterolemia (FH) results in elevated levels of blood lipids including total choles...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Item does not contain fulltextThe majority of patients with the autosomal dominant disorder familial...
Item does not contain fulltextFamilial Hypercholesterolemia (FH) results in elevated levels of blood...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
The majority of patients with the autosomal dominant disorder familial hypercholesterolemia (FH) car...
F�amilial hypercholesterolaemia (FH) is an autosomal dominant inherited disease of lipid metabolism ...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by a multitude of low-den...
Familial Hypercholesterolemia (FH) results in elevated levels of blood lipids including total choles...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Item does not contain fulltextThe majority of patients with the autosomal dominant disorder familial...
Item does not contain fulltextFamilial Hypercholesterolemia (FH) results in elevated levels of blood...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
The majority of patients with the autosomal dominant disorder familial hypercholesterolemia (FH) car...
F�amilial hypercholesterolaemia (FH) is an autosomal dominant inherited disease of lipid metabolism ...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
OBJECTIVE: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) ge...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...